Skip to main content

Acetazolamide

NDC 67457-853 · Mylan Institutional LLC

Generic nameacetazolamide sodium
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)ACETAZOLAMIDE SODIUM
Strength500 mg/5mL
Pharmacologic classCarbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
Marketing categoryANDA

Packages

67457-853-50 — 1 VIAL in 1 CARTON (67457-853-50) / 5 mL in 1 VIAL

Billed under HCPCS

J1120 — Injection, acetazolamide sodium, up to 500 mg Medicare Part B payment limit (ASP + 6%): $28.13

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9006 — Acetazolamide, 0143-9503 — Acetazolamide, 23155-313 — Acetazolamide, 23155-831 — Acetazolamide, 25021-839 — Acetazolamide Sodium, 39822-0190 — Acetazolamide, 68083-661 — Acetazolamide

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.2X1 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), T50.2X2 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, T50.2X3 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, T50.2X4 — Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, T50.2X5 — Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, T50.2X6 — Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics